G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 28.05 SEK 3.13% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genovis AB
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
PP&E Net
kr91.4m
CAGR 3-Years
100%
CAGR 5-Years
66%
CAGR 10-Years
44%
AddLife AB
STO:ALIF B
PP&E Net
kr1.1B
CAGR 3-Years
34%
CAGR 5-Years
57%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
PP&E Net
kr727.4m
CAGR 3-Years
76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
PP&E Net
kr313m
CAGR 3-Years
36%
CAGR 5-Years
23%
CAGR 10-Years
22%
MedCap AB (publ)
STO:MCAP
PP&E Net
kr382.6m
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
31%
M
Magle Chemoswed Holding AB
STO:MAGLE
PP&E Net
kr107m
CAGR 3-Years
1%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Genovis AB
Glance View

Market Cap
1.8B SEK
Industry
Life Sciences Tools & Services

Genovis AB engages in the research and development of enzyme products. The company is headquartered in Lund, Skane. The company went IPO on 2005-11-11. The firm offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer, inflammatory and autoimmune diseases. The portfolio comprises FabRICATOR, a genetically modified enzyme the cleaves antibodies in two parts, and IgGZERO, a protein that specifically cleaves the sugar molecules that occur naturally on antibodies. The products within the nano portfolio are primarily directed at the preclinical market. The firm markets and sells its products through dealers and distributors in the European, North American and Asian continents. As of December 31, 2011, it operated a wholly owned subsidiary, Eijdo Research AB.

GENO Intrinsic Value
24.64 SEK
Overvaluation 12%
Intrinsic Value
Price
G

See Also

What is Genovis AB's PP&E Net?
PP&E Net
91.4m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's PP&E Net amounts to 91.4m SEK.

What is Genovis AB's PP&E Net growth rate?
PP&E Net CAGR 10Y
44%

Over the last year, the PP&E Net growth was 398%. The average annual PP&E Net growth rates for Genovis AB have been 100% over the past three years , 66% over the past five years , and 44% over the past ten years .

Back to Top